{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:58:52Z","timestamp":1773658732370,"version":"3.50.1"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T00:00:00Z","timestamp":1375056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0070428","type":"journal-article","created":{"date-parts":[[2013,7,29]],"date-time":"2013-07-29T21:21:20Z","timestamp":1375132880000},"page":"e70428","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Telomerase Contributes to Fludarabine Resistance in Primary Human Leukemic Lymphocytes"],"prefix":"10.1371","volume":"8","author":[{"given":"May","family":"Shawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsz Wai","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Martinez-Marignac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei M.","family":"Gryaznov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan P.","family":"Lees-Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarit E.","family":"Assouline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Autexier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Aloyz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.blre.2008.03.003","article-title":"New prognostic markers in chronic lymphocytic leukemia","volume":"22","author":"C Moreno","year":"2008","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V87.7.2615.bloodjournal8772615","article-title":"B-chronic lymphocytic leukemia: a malignancy of anti-self B cells","volume":"87","author":"F Caligaris-Cappio","year":"1996","journal-title":"Blood"},{"key":"ref3","first-page":"4918","article-title":"Telomere Length and Telomerase Activity Predict Survival in Patients with B Cell Chronic Lymphocytic Leukemia","volume":"58","author":"OE Bechter","year":"1998","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2141.1999.01620.x","article-title":"Telomerase activity in chronic lymphoproliferative disorders of B-cell lineage","volume":"106","author":"L Trentin","year":"1999","journal-title":"Br J Haematol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2003-04-1345","article-title":"Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations","volume":"103","author":"RN Damle","year":"2004","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.leu.2404544","article-title":"Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients","volume":"21","author":"I Ricca","year":"2007","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.leu.2404607","article-title":"Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome","volume":"21","author":"L Terrin","year":"2007","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3324\/haematol.2011.049874","article-title":"Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes","volume":"97","author":"E Rampazzo","year":"2012","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.biochem.75.103004.142412","article-title":"The structure and function of telomerase reverse transcriptase","volume":"75","author":"C Autexier","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3835(01)00838-2","article-title":"Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors","volume":"178","author":"M Akiyama","year":"2002","journal-title":"Cancer Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2275","article-title":"Telomerase and cancer therapeutics","volume":"8","author":"CB Harley","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/bies.20793","article-title":"The many faces of telomerase: emerging extratelomeric effects","volume":"30","author":"FM Bollmann","year":"2008","journal-title":"Bioessays"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.neuroscience.2006.11.052","article-title":"DNA damage responses in neural cells: Focus on the telomere","volume":"145","author":"P Zhang","year":"2007","journal-title":"Neuroscience"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/jcp.2006.040956","article-title":"Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase","volume":"60","author":"EC Obermann","year":"2007","journal-title":"J Clin Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1182\/blood.V85.9.2315.bloodjournal8592315","article-title":"Telomerase activity in normal leukocytes and in hematologic malignancies","volume":"85","author":"CM Counter","year":"1995","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1517\/14656566.7.12.1641","article-title":"Fludarabine in chronic lymphocytic leukaemia","volume":"7","author":"T Elter","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s11912-007-0048-6","article-title":"The role of DNA repair in chronic lymphocytic leukemia pathogenesis and chemotherapy resistance","volume":"9","author":"D Sampath","year":"2007","journal-title":"Curr Oncol Rep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1158\/1078-0432.CCR-07-5158","article-title":"DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia","volume":"14","author":"E Willmore","year":"2008","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1046\/j.1365-2141.1999.01448.x","article-title":"Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms","volume":"105","author":"AR Pettitt","year":"1999","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mrfmmm.2008.08.013","article-title":"Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells","volume":"646","author":"M de Campos-Nebel","year":"2008","journal-title":"Mutat Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1101\/gad.1646608","article-title":"Mechanistic flexibility as a conserved theme across 3 billion years of nonhomologous DNA end-joining","volume":"22","author":"J Gu","year":"2008","journal-title":"Genes Dev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1093\/nar\/gkp636","article-title":"The human telomerase RNA component, hTR, activates the DNA-dependent protein kinase to phosphorylate heterogeneous nuclear ribonucleoprotein A1","volume":"37","author":"NS Ting","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/nar\/gki342","article-title":"Human Ku70\/80 interacts directly with hTR, the RNA component of human telomerase","volume":"33","author":"NS Ting","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"12430","DOI":"10.1073\/pnas.0903362106","article-title":"Ku86 represses lethal telomere deletion events in human somatic cells","volume":"106","author":"Y Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1073\/pnas.022649699","article-title":"Ku86 is essential in human somatic cells","volume":"99","author":"G Li","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1182\/blood-2007-09-111245","article-title":"Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia","volume":"111","author":"D Poncet","year":"2008","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1038\/sj.onc.1208760","article-title":"Lipid modification of GRN163, an N3\u2032\u2013 &gt;P5\u2032 thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition","volume":"24","author":"B-S Herbert","year":"2005","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2141.2008.07418.x","article-title":"Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro","volume":"143","author":"L Amrein","year":"2008","journal-title":"Br J Haematol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1158\/0008-5472.CAN-06-2306","article-title":"Antiadhesive effects of GRN163L \u2013 an oligonucleotide N3\u2032-&gt;P5\u2032 thio-phosphoramidate targeting telomerase","volume":"67","author":"SR Jackson","year":"2007","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1093\/nar\/29.16.3385","article-title":"Human telomerase RNA-protein interactions","volume":"29","author":"F Bachand","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.dnarep.2004.03.041","article-title":"Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells","volume":"3","author":"AA Goodarzi","year":"2004","journal-title":"DNA Repair (Amst)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/nar\/27.10.2227","article-title":"<italic>Tetrahymena<\/italic> telomerase ribonucleoprotein RNA-protein interactions","volume":"27","author":"C Autexier","year":"1999","journal-title":"Nucleic Acids Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1124\/jpet.106.118356","article-title":"Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase","volume":"321","author":"L Amrein","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/leu.2011.110","article-title":"ZRF4, a combi-molecule with increased efficacy as compared with the individual components in chronic lymphocytic leukemia lymphocytes in vitro","volume":"25","author":"L Amrein","year":"2011","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Hebb J, Assouline S, Rousseau C, Desjardins P, Caplan S, et al. (2010) A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients. Cancer Chemother Pharmacol.","DOI":"10.1007\/s00280-010-1530-7"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2141.1998.00813.x","article-title":"In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia","volume":"102","author":"F Morabito","year":"1998","journal-title":"Br J Haematol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12185-010-0750-2","article-title":"Telomeres and prognosis in patients with chronic lymphocytic leukaemia","volume":"93","author":"L Sellmann","year":"2011","journal-title":"Int J Hematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1359-6349(10)72095-4","article-title":"Imetelstat sodium (GRN163L), a telomerase inhibitor: tolerability, pharmacokinetics and pharmacodynamic activity using an intermittent once every four weeks dosing schedule in patients with advanced solid tumors","volume":"8","author":"MJ Ratain","year":"2010","journal-title":"Ejc Supplements"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood.V98.3.814","article-title":"p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation","volume":"98","author":"AR Pettitt","year":"2001","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2003-03-0989","article-title":"CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells","volume":"102","author":"S Deaglio","year":"2003","journal-title":"Blood"},{"key":"ref41","first-page":"3931","article-title":"A novel telomerase template antagonist (GRN163) as a potential anticancer agent","volume":"63","author":"A Asai","year":"2003","journal-title":"Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"15566","DOI":"10.1074\/jbc.M201266200","article-title":"Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate","volume":"277","author":"E Pascolo","year":"2002","journal-title":"J Biol Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/mol.105.011494","article-title":"Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment","volume":"68","author":"RJ Ward","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref44","first-page":"1789","article-title":"Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin","volume":"58","author":"G Christodoulopoulos","year":"1998","journal-title":"Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.bbamcr.2012.08.003","article-title":"Telomerase antagonist imetelstat inhibits esophageal cancer cell growth and increases radiation-induced DNA breaks","volume":"1823","author":"XP Wu","year":"2012","journal-title":"Biochimica Et Biophysica Acta-Molecular Cell Research"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4161\/cc.4.3.1565","article-title":"The double life of the Ku protein: facing the DNA breaks and the extracellular environment","volume":"4","author":"C Muller","year":"2005","journal-title":"Cell Cycle"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/sj.onc.1202640","article-title":"DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues","volume":"18","author":"U Moll","year":"1999","journal-title":"Oncogene"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/path.1164","article-title":"Heterogeneous expression of Ku70 in human tissues is associated with morphological and functional alterations of the nucleus","volume":"198","author":"EK Choi","year":"2002","journal-title":"Journal of Pathology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2011.03.020","article-title":"Processive and distributive extension of human telomeres by telomerase under homeostatic and nonequilibrium conditions","volume":"42","author":"Y Zhao","year":"2011","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.molcel.2007.07.020","article-title":"Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation","volume":"27","author":"G Cristofari","year":"2007","journal-title":"Mol Cell"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Brennan SK, Wang Q, Tressler R, Harley C, Go N, et al. (2010) Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms. PLoS One 5.","DOI":"10.1371\/journal.pone.0012487"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1182\/blood-2004-11-4516","article-title":"Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL","volume":"106","author":"B Austen","year":"2005","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0070428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T01:01:29Z","timestamp":1596243689000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0070428"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Nicot","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,29]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0070428","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,29]]}}}